David Halpert
Nephrology · Atlantis, FLNPI 1003897810
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.2% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $537 and has fallen 90.8% since, to $50 in 2025. That places this record below the midpoint for nephrology clinicians in FL, where the typical reported total is $1,407.
Across 29 payments — averaging $26.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Misonix Inc$143
- Otsuka America Pharmaceutical, Inc.$118
- AstraZeneca$114
- Vifor Pharma, Inc.$94
- Daiichi Sankyo Inc.$58
- Mallinckrodt Enterprises LLC$53
- plus $176 from 7 others
Across 192 payments — averaging $21,638 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.4M
- Modernatx, Inc.$1.3M
- AstraZeneca$703K
- GSK$365K
- Eli Lilly$294K
- AbbVie$17K
What the payments were for
- Food & beverage$69091%
- Education$679%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Misonix Inc | 1 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $118 |
| AstraZeneca | 8 | $114 |
| Vifor Pharma, Inc. | 5 | $94 |
| Daiichi Sankyo Inc. | 1 | $58 |
| Mallinckrodt Enterprises LLC | 2 | $53 |
| Genentech, Inc. | 1 | $50 |
| Nuwellis, Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $28 |
| Amgen | 1 | $22 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Akebia Therapeutics Inc | 1 | $7 |
How this compares
$757 in reported general payments places this provider in the 35th percentile of 756 nephrology providers in Florida.
Other nephrology in Atlantis
- Jose ArrascueAtlantis$39K
- Arvind MadanOrlando$943K
- John CopleyWeston$934K
- Jorge LarranagaKissimmee$825K
- Carlos BejarFort Lauderdale$530K
- Wayne KotzkerFort Lauderdale$472K
- Jason RothschildTemple Terrace$413K
- Daniel PatelDaytona Beach$227K
- Rafael Baez BonillaFort Lauderdale$175K
- Gabriel ContrerasMiami$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.